Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116801) titled 'Efficacy of an Anti-Acne Molecule in Sebum Control' on Sept. 1.

Study Type: PMS

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: Equilion Pvt Ltd

Intervention: Intervention1: Test Product: Anti-Acne molecule: For Phase-1: Apply the product on the left side of the Face and keep the right side blank for 30 min, For Phase 2: Use the Product twice a day, Duration: 14 Days, Rout of Application: Topical

Control Intervention1: Not Applicable: Not Applicable

Recruitment...